Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sterling S.p.A. is an Italian pharmaceutical company specializing in the development and manufacturing of steroidal Active Pharmaceutical Ingredients (APIs). Founded in 1976 and headquartered in Solomeo, Italy, the company operates as a Contract Development and Manufacturing Organization (CDMO) providing services from process development to large-scale GMP production. Its expertise covers a wide range of therapeutic areas, including oncology, respiratory diseases, dermatology, and contraception. Sterling maintains high-quality standards with facilities audited by the FDA and AIFA, and it serves global markets including the US, Europe, and Asia. The company has recently expanded its capabilities to include protein kinase inhibitors and respiratory products at its manufacturing site in Malta.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sterling Spa.